Moreover, several previous studies have indicated that PCAT18 could inhibit the proliferation, migration, and invasion of gastric cancer (GC) cells, which could provide a theoretical basis for GC therapy (27–29). This evidence concerns the gene PCAT18 and gastric cancer.